|
|
|
9th Global Drug Delivery & Formulation Summit |
 |
|
12-14 March 2018
Maritim proArte Hotel Berlin
The growth of biopharma, patient compliance issues and ever
increasing regulatory requirements have encouraged us to adopt a drug delivery
mind set from discovery through to production.
Every year we see innovation and breakthroughs at all levels
of drug and formulation development. From big pharma, through the smaller
biotechnology companies all the way to university research teams and spin outs.
The DDF Summit brings the most interesting studies and
exciting technologies to you. This year there will be 4 dedicated streams
focusing on Small Molecules, Biologics, Technology & Innovation and for the
first-time Device Development.
You’ll find new technologies, concepts and case studies in
areas such as… • Less traditional delivery routes including nasal, ocular & subcutaneous
• Targeted and controlled release technologies and nanoparticles
• Increasing stability of amorphous solid dispersion
• QbD in biopharmaceutical development
• Formulation strategies for multiple injection dosing
• Oral delivery of peptides
• Continuous manufacturing and processing for improved efficiency
• User friendly technologies for improving patient convenience and
compliance
• Regulatory strategies for combination products
• Drug stability and material selection in combination products
Visit www.ddfevent.comor contact maxconferences@markallengroup.comfor more information. |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
Nordic Life Science Days 10/12 September 2019
10-12 September 2019, Malmo Sweden
Nordic Life Science Days is the largest Nordic partnering conference for the global Life
Science industry.
Bringing together the best talents in Life Science, offering amazing networking and
partnering opportunities, providing inputs and content on the most recent trends.
Nordic Life Science Days attracts leading decision makers from the Life Science sector,
not only from biotech, pharma and medtech but also from finances, research, policy and
regulatory authorities.
More info >> |
|
 |
White Papers |
 |
|
Overcoming research challenges with Adaptive Trials
PCI Pharma Services
There has been cause for concern within the pharmaceutical industry over
the last five years, regarding increasing research and development
costs, combined with a fall in the number of new drugs brought to
market. In an attempt to overcome this issue there has been a
significant rise in the use of adaptive clinical trial designs, whilst
saving time and money as well as facilitating more effective decision
making. One of the biggest challenges that pharmaceutical companies have
experienced has been delivering compliant clinical trials supplies
across diverse patient populations in the relatively short timeframes
that adaptive trial designs require, remaining focused on ensuring that
patient compliance and product quality is in no way compromised. This
demand has led to the launch of fast response services that support
Research and Development in responding to changing dosing regimens
mid-trial.
More info >> |
|
 |
News and Press Releases |
 |
MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development
MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >> |
|
|
